$70 Million Awarded against Johnson & Johnson in Third Jury Verdict

ST. LOUIS – A major victory for a plaintiff in the Johnson & Johnson talcum powder litigation took place today, with a jury awarding $70.075 million to Ms.

2019 The Trial Lawyer A-List Article – TV, Digital, and the 360-Degree Blended Approach

When reviewing your mass tort media strategy, there is no one formula that applies to all firms. Instead of focusing on television only or digital, it’s best to take an agnostic approach.

CAMG and CEO Steve Nober in The Wall Street Journal

Mass-Tort Machine Powers Wave of Roundup Lawsuits CAMG and CEO Steve Nober were featured in The Wall Street Journal article, “Inside the Mass-Tort Machine That Powers Thousands of Roundup Lawsuits”.

Fall 2019 The Trial Lawyer Article

As an emerging tort, JUUL campaign marketing doesn’t yet have the historical data and performance metrics to draw from. How can you proceed with planning your JUUL campaign strategy?

J&J Hit With $70 Million Risperdal Verdict Over Male Breasts

A $70 million verdict won by a Tennessee teenager who blamed Johnson & Johnson’s Risperdal drug for causing him to grow female breasts dwarfs awards to other users of the antipsychotic medication who suffered the same side effect.

J&J Must Pay $72 Million Over Talc Tied to Woman’s Cancer

Jury foreman says it was clear J&J was `hiding something’ Company faces about 1,200 more suits over talc products Johnson & Johnson must pay $72 million to the family of a woman who blamed her fatal ovarian cancer on the company’s talcum powder in the first state-court case over the claims to go to trial.

Johnson & Johnson hit with $500 million verdict in hip implant trial

NEW YORK (Reuters) – Johnson & Johnson and its DePuy unit were ordered by a Texas federal jury on Thursday to pay about $500 million to five plaintiffs who said they were injured by Pinnacle metal-on-metal hip implants.

July 2019 PILMMA Insiders Journal Article

Is Your Phone Protocol Costing you Client? By Steve Nober If you aren’t reviewing your phone protocol, you may be losing clients. In this article from the July 2019 PILMMA Insiders’ Edition, Steve Nober shares how you can analyze your firm’s intake process, make improvements, and improve your retainer conversions.

March 2019 PILMMA Article

Marketing Review: Tools for Success by Steve Nober In today’s competitive legal market, you need a systematic approach to run successful marketing campaigns. In this article from the PILMMA Insiders’ Edition, CAMG’s Steve Nober shares the 3 tools you need to beat the competition with smarter marketing.

NBC Special Report: Medical Device to Stop Blood Clots Associated With 27 Fatalities

Medical Device to Stop Blood Clots Associated With 27 Fatalities Click here to watch the first part of the NBC Special Investigation Did Manufacturer of Medical Device Linked to 27 Deaths Ignore Safety Concerns?

Over 500,000 Open Heart Surgery Patients at Risk of Life-Threatening Infection

Stöckert 3T and LivaNova PLC Heater-Cooler Devices Possibly Contaminated During Manufacturing According to the Centers for Disease Control (CDC), Stöckert 3T and LivaNova PLC Heater-Cooler devices, which are used during open heart surgery, were possibly contaminated during manufacturing.

Steve Nober Presents PILMMA Webinar

Steve Nober presented a webinar to PILMMA members and other attorneys on Competitive Insights and Key Tools for Targeting – Best Practices to WIN in Your Local Market, June 21, 2019.